Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura L Gillison

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Cancer|November 5, 2008
Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003A Blythe Ryerson, Edward S Peters, Steven S Coughlin, et al.
Oral Oncology|April 2, 2023
Noninvasive genomic profiling of somatic mutations in oral cavity cancersYuanxin Xi, Marcelo V Negrao, Keiko Akagi, et al.
Journal of the National Cancer Institute|February 6, 2025
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling studyRebecca Landy, Gregory W Haber, Barry I Graubard, et al.
Oral Oncology|August 19, 2019
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by ageNabil F Saba, George Blumenschein, Joel Guigay, et al.
Oral Oncology|June 23, 2015
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyKaren S Anderson, Jennifer E Gerber, Gypsyamber D'Souza, et al.
Journal of the National Cancer Institute|January 19, 2023
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling studyRebecca Landy, Gregory Haber, Barry I Graubard, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancerGarrett L Jensen, Pierre Blanchard, G Brandon Gunn, et al.
Cancer Discovery|January 30, 2023
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV IntegrationKeiko Akagi, David E Symer, Medhat Mahmoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234Paul M Harari, Jonathan Harris, Merrill S Kies, et al.
Scientific Reports|December 17, 2017
Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancerDaniela Börnigen, Boyu Ren, Robert Pickard, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Cancer|November 5, 2008
Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003A Blythe Ryerson, Edward S Peters, Steven S Coughlin, et al.
Oral Oncology|April 2, 2023
Noninvasive genomic profiling of somatic mutations in oral cavity cancersYuanxin Xi, Marcelo V Negrao, Keiko Akagi, et al.
Journal of the National Cancer Institute|February 6, 2025
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling studyRebecca Landy, Gregory W Haber, Barry I Graubard, et al.
Oral Oncology|August 19, 2019
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by ageNabil F Saba, George Blumenschein, Joel Guigay, et al.
Oral Oncology|June 23, 2015
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyKaren S Anderson, Jennifer E Gerber, Gypsyamber D'Souza, et al.
Journal of the National Cancer Institute|January 19, 2023
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling studyRebecca Landy, Gregory Haber, Barry I Graubard, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancerGarrett L Jensen, Pierre Blanchard, G Brandon Gunn, et al.
Cancer Discovery|January 30, 2023
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV IntegrationKeiko Akagi, David E Symer, Medhat Mahmoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234Paul M Harari, Jonathan Harris, Merrill S Kies, et al.
Scientific Reports|December 17, 2017
Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancerDaniela Börnigen, Boyu Ren, Robert Pickard, et al.
Pageof 16